Faculty

Institution

Unit

Venue

Michael Nishimura

Loyola University Chicago

Affiliations

Stritch School of Medicine

Surgery

NoneMichael Nishimura is currently serving as a Stritch School Of Medicine faculty at Loyola University Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Nishimura

Loyola University Chicago

You can click a keyword to filter the displayed items

immunology cancer immunotherapy oncology immune responses dermatology cancer research immunotherapy tumor biology medicine adaptive immune system medicinal research cell biology cellular therapy t-regulatory cell clinical immunology cancer treatment cancer biology cellular immune responses melanoma cancer care hematology gene expression tumor targeting leukemia tumor suppressors cell transplantation molecular cancer cancer genetics cancer cells oncogenes molecular immunology cell death hla typing cancer management skin cancer apoptosis innate immune system pharmacotherapy cell therapy viral oncology lymphoid neoplasia peptides cell regulation cancer growth histocompatibility host specificity cancer immunosurveillance cytokines adoptive transfer experimental medicine cell research enzyme inhibition immunochemistry cutaneous biology single-cell analysis hepatocellular carcinoma viral hepatitis antigen recognition tumor-infiltrating lymphocytes metastatic melanoma liver transplantation medical mycology experimental dermatology gene characterization t-cell receptor repertoire t-cell receptor t-cell receptor frequencies myeloid-derived suppressor cells doxorubicin-cyclophosphamide chemotherapy clinical cancer stage metastatic tumor burden worldwide task force cancer classification tumor antigen-reactive tcr efficient transfer human peripheral blood cancer immunology immunoediting pathology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract Lb343: Golgihi T Cells Exhibit Reduced Susceptibility to Exhaustion and Improved Tumor Control. Cancer Research (2024)

Nathaniel OberholtzerParamita ChakrabortyMohamed Faisal KassirJames DressmanZacharia HedleyGina ScurtiMonika GoozLauren E. BallElizabeth HillAnand S. MehtaEduardo N. MaldonadoMichael I. NishimuraBesim OgretmenShikhar Mehrotra

radiation oncologytumor biologycancer immunotherapyimmunologycellular therapycancer researchimmune responsesadaptive immune systemcancer managementhealth sciencesoncologycancer biology

Final Results of a Phase I Trial of Herv-E Tcr Transduced T Cells for the Treatment of Hla-a*11 Patients With Metastatic Clear Cell Renal Cell Carcinoma (Mccrcc).. Journal of Clinical Oncology (2024)

Rosa NadalStefan BarisicGina M. ScurtiElena CherkasovaLong ChenKristen WoodSteven L. HighfillBrian WellsGeorg AueReem ShalabiThomas E. HughesXin TianYifei XuAshkan A. MalayeriRobert N. RegerMichael I. NishimuraRichard W. Childs

immunologygenitourinary cancerspharmacologycancer immunotherapyimmunotherapycancer researchcancer treatmentoncogenesradiation oncologymedicinal researchviral oncologyhla typingcellular therapycancer carehost specificityherv-e tcrclinical researchleukemiaoncology

Data From Efficacy of Adoptive T-Cell Therapy is Improved by Treatment With the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-Cell Death. (2023)

Matthew J. ScheffelGina ScurtiPatricia SimmsElizabeth Garrett-MayerShikhar MehrotraMichael I. NishimuraChristina Voelkel-Johnson

immunologyimmunotherapyactivation-induced t-cell deathpharmacologyadoptive t-cell therapyantioxidant n-acetyl cysteinetherapeutic efficacy

Data From Endothelin-1–Mediated Drug Resistance in I Egfr /I -Mutant Non-Small Cell Lung Carcinoma. (2023)

Inés PulidoStephen OllosiSalvador AparisiJeffrey H. BeckerAlicia Aliena-ValeroMarta BenetMaría L. RodríguezAdrián LópezEva Tamayo-TorresLourdes Chuliá-PerisJuan Carlos García-CañaverasMargaret SoucherayAnnika V. DalheimJuan B. SalomWei QiuSimon KajaJavier Alcácer Fernández-CoronadoSandra AlandesJavier AlcácerFátima Al-ShahrourJeffrey A. BorgiaOscar JuanMichael I. NishimuraAgustín LahozJulián CarreteroTakeshi Shimamura

oncogenespathologytumor targetingtumor biologycancer biologyanti-cancer agentscancer immunotherapymedicinal researchmolecular cancerlung cancerdrug resistancecancer researchcancer imagingpharmacologycancer cellscancer geneticscancer genomicsgenetics

Data From Lack of P53 Augments Antitumor Functions in Cytolytic T Cells. (2023)

Anirban BanerjeeKrishnamurthy ThyagarajanShilpak ChatterjeeParamita ChakrabortyPravin KesarwaniMyroslawa SoloshchenkoMazen Al-HommraniKristina AndrijauskaiteKelly MoxleyHarinarayanan JanakiramanMatthew J. ScheffelKristi HelkeKent ArmensonViswanathan PalanisamyMark P. RubinsteinElizabeth-Garrett MayerDavid J. ColeChrystal M. PaulosChristina Voelkel-JohnsonMichael I. NishimuraShikhar Mehrotra

tumor biologyt-regulatory cellcancer immunotherapyimmunologycell biologycancer researchimmune responsestumor suppressorsdata sciencecancer geneticscancer genomicsoncologycancer biology

Data From Promoting Thiol Expression Increases the Durability of Antitumor T-Cell Functions. (2023)

Pravin KesarwaniAmir A. Al-KhamiGina ScurtiKrishnamurthy ThyagarajanNavtej KaurShahid HusainQuan FangOsama S. NagaPatricia SimmsGyda BeesonChristina Voelkel-JohnsonElizabeth Garrett-MayerCraig C. BeesonMichael I. NishimuraShikhar Mehrotra

health promotiontumor biologyantitumor t-cell functionscancer immunotherapyimmunologycancer researchimmune responsesadaptive immune systemdata sciencethiol expression

Meeting Highlights: The Third Marie SkŁOdowska-Curie Symposium on Cancer Research and Care at Roswell Park Comprehensive Cancer Center, Buffalo, Ny, September 20-22, 2023. Wiadomości Lekarskie (2023)

Pawel KalinskiKathleen M. KokolusRami AzrakMikhail Y. BerezinRenier BrentjensBrian CzernieckiSergii DubrovKara EatonShipra GandhiElizabeth A. GriffithsAndrew HylandAdam KisailusMarcin KortylewskiGary K. KoskiLeszek KotulaIwona ŁugowskaSandro MatosevicChristopher McAleerMichał MikułaMichael I. NishimuraKatie NoyesTetiana OrabinaPetar OzretićGyorgy ParaghMark ParascandolaVita PašukonienėAndras PerlDaniel J. Powell Jr.Waldemar PriebeElizabeth A. RepaskyMarek RudnickiAnurag K. SinghElżbieta SarnowskaKęstutis SužiedėlisAnna TitkovaKaren UtzWei-Zen WeiPiotr Rutkowski

cancer researchhealth sciencesoncology

Phase I Results of Human Endogenous Retrovirus Type-E (Herv-E) Tcr Transduced T-Cells in Patients (Pts) With Metastatic Clear Cell Renal Cell Carcinoma (Mccrcc).. Journal of Clinical Oncology (2023)

Rosa NadalStefan BarisicGina M. ScurtiElena CherkasovaLong ChenKristen WoodSteven L. HighfillBrian WellsGeorg AueReem ShalabiThomas E. HughesXin TianYifei XuAshkan A. MalayeriMohammadhadi H. BagheriRobert N. RegerMichael I. NishimuraRichard W. Childs

medical virologyradiation oncologyclinical mycologyvirologyt-regulatory cellcancer immunotherapyimmunologycell transplantationmedicinal researchdermatologycellular therapygenitourinary cancersviral oncologycancer researchcellular immune responsesclinical researchcancer careoncology

Supplementary Figure 3 From Promoting Thiol Expression Increases the Durability of Antitumor T-Cell Functions. (2023)

health promotionantitumor t-cell functionscancer immunotherapyimmunologyimmune responsesthiol expression

Supplementary Figure Legends From Lack of P53 Augments Antitumor Functions in Cytolytic T Cells. (2023)

oncogenesapoptosistumor biologycancer immunotherapyimmunologymedicinal researchdermatologymolecular cancercarcinogenesiscellular therapycancer researchtumor suppressorspharmacologycancer geneticscancer genomicsoncologycancer biology

1
2
3
4
5
16
10 / page

Michael Nishimura

Loyola University Chicago

Affiliations

Stritch School of Medicine

Surgery

NoneMichael Nishimura is currently serving as a Stritch School Of Medicine faculty at Loyola University Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Nishimura

Loyola University Chicago

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract Lb343: Golgihi T Cells Exhibit Reduced Susceptibility to Exhaustion and Improved Tumor Control. Cancer Research (2024)

radiation oncologytumor biologycancer immunotherapyimmunologycellular therapycancer researchimmune responsesadaptive immune systemcancer managementhealth sciencesoncologycancer biology

Data From Efficacy of Adoptive T-Cell Therapy is Improved by Treatment With the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-Cell Death. (2023)

Matthew J. ScheffelGina ScurtiPatricia SimmsElizabeth Garrett-MayerShikhar MehrotraMichael I. NishimuraChristina Voelkel-Johnson

immunologyimmunotherapyactivation-induced t-cell deathpharmacologyadoptive t-cell therapyantioxidant n-acetyl cysteinetherapeutic efficacy

Data From Endothelin-1–Mediated Drug Resistance in I Egfr /I -Mutant Non-Small Cell Lung Carcinoma. (2023)

Data From Lack of P53 Augments Antitumor Functions in Cytolytic T Cells. (2023)

tumor biologyt-regulatory cellcancer immunotherapyimmunologycell biologycancer researchimmune responsestumor suppressorsdata sciencecancer geneticscancer genomicsoncologycancer biology

Data From Promoting Thiol Expression Increases the Durability of Antitumor T-Cell Functions. (2023)

health promotiontumor biologyantitumor t-cell functionscancer immunotherapyimmunologycancer researchimmune responsesadaptive immune systemdata sciencethiol expression

cancer researchhealth sciencesoncology

Rosa NadalStefan BarisicGina M. ScurtiElena CherkasovaLong ChenKristen WoodSteven L. HighfillBrian WellsGeorg AueReem ShalabiThomas E. HughesXin TianYifei XuAshkan A. MalayeriMohammadhadi H. BagheriRobert N. RegerMichael I. NishimuraRichard W. Childs

Supplementary Figure 3 From Promoting Thiol Expression Increases the Durability of Antitumor T-Cell Functions. (2023)

health promotionantitumor t-cell functionscancer immunotherapyimmunologyimmune responsesthiol expression

Supplementary Figure Legends From Lack of P53 Augments Antitumor Functions in Cytolytic T Cells. (2023)

1
2
3
4
5
16
10 / page

Similar Faculty Members

Amy B Heimberger

Institution

Northwestern University

brain tumor research

oncology

Herbert Kim Lyerly

Institution

Duke University

immunology

oncology

Eduardo M. Sotomayor, MD

Institution

University of South Florida

cellular therapy

lymphoid neoplasia

Olivera J. Finn

Institution

University of Pittsburgh

cancer letter

immunotherapy

Walter J. Storkus

Institution

University of Pittsburgh

immunomodulation

tumor immunobiology

Steven M. Dubinett

Institution

University of California, Los Angeles

oncology

cancer research

Bruce L. Levine

Institution

University of Pennsylvania

gene therapy

cell therapy

David Munn

Institution

Augusta University

immunology

medicine

Robert Anders

Institution

Johns Hopkins University

oncology

cancer research

Kai Wucherpfennig

Institution

Harvard University

immunology

immune responses

Similar Faculty Members

Amy B Heimberger

Institution

Northwestern University

brain tumor research

oncology

Herbert Kim Lyerly

Institution

Duke University

immunology

oncology

Eduardo M. Sotomayor, MD

Institution

University of South Florida

cellular therapy

lymphoid neoplasia

Olivera J. Finn

Institution

University of Pittsburgh

cancer letter

immunotherapy

Walter J. Storkus

Institution

University of Pittsburgh

immunomodulation

tumor immunobiology

Steven M. Dubinett

Institution

University of California, Los Angeles

oncology

cancer research

Bruce L. Levine

Institution

University of Pennsylvania

gene therapy

cell therapy

David Munn

Institution

Augusta University

immunology

medicine

Robert Anders

Institution

Johns Hopkins University

oncology

cancer research

Kai Wucherpfennig

Institution

Harvard University

immunology

immune responses